Sulzberger Gabrielle 4

What Happened Gabrielle Sulzberger, a director of Eli Lilly & Co. (LLY), received a grant/award of 4.786 shares (transaction code A) on February 17, 2026. The filing values the award at $1,036.05 per share, for a total of approximately $4,959. This was an award of deferred stock units in lieu of cash director compensation, not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-02-17; filing date: 2026-02-18 (timely filing).
• Award: 4.786 shares at $1,036.05 per share; total value ≈ $4,959.
• Transaction code: A (grant/award/other acquisition).
• Shares owned after transaction: Not specified in the excerpt — see the Form 4 for total holdings.
• Footnote: At the reporting person's election, the shares were deferred under the Lilly Directors' Deferral Plan and will be settled in shares following the reporting person's separation from service.

Context Director awards like this are routine compensation and typically reflect board pay rather than a trading signal. Because these are deferred stock units (not immediately delivered shares) and the amount is modest relative to company market cap, this single award is not, by itself, a strong indicator of insider market sentiment.